Lorazepam Orion
Benzodiazepine anxiolytic for short-term treatment of severe anxiety in adults
Lorazepam Orion contains the active substance lorazepam, a benzodiazepine medication used for the short-term treatment of severe and disabling anxiety in adults. It works by enhancing the calming neurotransmitter GABA in the brain. Due to the risk of dependence, treatment is limited to 2–4 weeks. This page covers uses, dosage, side effects, drug interactions, and important safety warnings based on international clinical guidelines.
Quick Facts
Key Takeaways
- Lorazepam Orion is a benzodiazepine prescribed only for short-term relief of severe, disabling anxiety in adults.
- Treatment should not normally exceed 4 weeks including tapering, due to the significant risk of physical and psychological dependence.
- Never stop Lorazepam Orion abruptly — your doctor will gradually reduce the dose to prevent withdrawal symptoms.
- Combining lorazepam with opioids, alcohol, or other CNS depressants can cause life-threatening respiratory depression.
- Do not drive or operate machinery while taking this medication, as it causes drowsiness and impaired coordination.
What Is Lorazepam Orion and What Is It Used For?
Lorazepam Orion belongs to the benzodiazepine class of medications, a group of drugs that act on the central nervous system to produce calming, anxiolytic (anxiety-reducing), sedative, muscle-relaxant, and anticonvulsant effects. The active ingredient, lorazepam, was first developed in 1977 and is included on the World Health Organization (WHO) Model List of Essential Medicines, reflecting its established role in medical practice.
The primary mechanism of action of lorazepam involves enhancing the activity of gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain. By binding to specific GABA-A receptor subunits, lorazepam increases the frequency of chloride ion channel opening, which hyperpolarizes neurons and reduces their excitability. This results in the characteristic anxiolytic, sedative, and muscle-relaxant properties of the drug.
Lorazepam Orion is specifically indicated for the short-term management of severe anxiety that is disabling or causes the patient significant distress. The anxiety may arise from various underlying causes, including generalized anxiety disorder (GAD), situational anxiety, or anxiety associated with other medical or psychiatric conditions. According to NICE guidelines (CG113), benzodiazepines should not be offered as first-line treatment for generalized anxiety disorder but may be considered for short-term crisis management.
It is important to understand that lorazepam is not a cure for anxiety but rather provides temporary symptomatic relief. Long-term management of anxiety disorders typically involves psychological therapies such as cognitive behavioral therapy (CBT), and, where appropriate, selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) as first-line pharmacological treatments. Lorazepam is reserved for situations where rapid relief is needed and the severity justifies the risks associated with benzodiazepine use.
Lorazepam may also be authorized for indications not covered in this patient information leaflet. Always follow your prescriber's instructions and ask your healthcare provider if you have questions about the specific reason for your prescription.
What Should You Know Before Taking Lorazepam Orion?
Contraindications
There are several situations in which Lorazepam Orion must not be used. These absolute contraindications are based on the potential for serious, life-threatening adverse effects:
- Hypersensitivity: Do not take Lorazepam Orion if you are allergic to lorazepam, other benzodiazepines, or any of the excipients listed in the composition section.
- Sleep apnea syndrome: The medication can worsen breathing irregularities during sleep, as it depresses respiratory drive.
- Severe respiratory insufficiency: Patients with severe chronic obstructive pulmonary disease (COPD) or other conditions causing significant breathing difficulties must avoid this medication, as lorazepam can further suppress respiration.
- Myasthenia gravis: This autoimmune neuromuscular disorder causes severe muscle weakness. Lorazepam's muscle-relaxant properties can dangerously exacerbate this condition.
- Severe hepatic impairment: The liver plays an important role in metabolizing lorazepam, and severe liver disease can lead to dangerous accumulation of the drug.
Warnings and Precautions
Before starting treatment with Lorazepam Orion, inform your doctor if any of the following apply to you, as dose adjustments or additional monitoring may be necessary:
- Kidney impairment: Reduced renal function may affect drug clearance.
- Mild to moderate liver impairment: Lower doses may be required.
- Elderly or frail patients: Increased sensitivity to benzodiazepines, higher risk of falls, confusion, and paradoxical reactions.
- Chronic respiratory disease: Even mild respiratory compromise warrants careful monitoring.
- Acute narrow-angle glaucoma: Benzodiazepines may affect intraocular pressure.
- History of substance misuse: Including alcohol, recreational drugs, or prescription drug misuse — benzodiazepines carry a particularly high risk of misuse in these populations.
- History of seizures: Abrupt discontinuation of benzodiazepines can lower the seizure threshold.
Use of benzodiazepines, including Lorazepam Orion, can lead to physical and psychological dependence. The risk increases with higher doses and longer treatment durations. To minimize this risk, the lowest effective dose should be used for the shortest possible period. Treatment should generally not exceed 4 weeks, including the gradual tapering period. If treatment beyond 4 weeks is necessary, it must be reassessed regularly, ideally by the same prescriber who initiated treatment. The absolute maximum treatment duration is 2–3 months.
Drug misuse is a recognized risk with benzodiazepines. Misuse of this medication can lead to overdose and death. Always follow your doctor's dosing instructions exactly. Lorazepam may be sought by people who misuse prescription medications and should be stored securely, out of reach of others. Return any unused medication to a pharmacy for safe disposal.
Pregnancy and Breastfeeding
Lorazepam Orion should not be used during pregnancy, particularly during the first and third trimesters. Studies have shown that benzodiazepines can cross the placental barrier and may cause harm to the developing fetus. Use during late pregnancy can lead to neonatal withdrawal symptoms including irritability, feeding difficulties, and tremor, as well as floppy infant syndrome characterized by low muscle tone, lethargy, and respiratory difficulties in the newborn.
If you discover that you are pregnant while taking Lorazepam Orion, contact your doctor immediately. Do not stop the medication abruptly, as this can cause withdrawal symptoms. Your doctor will advise on a safe tapering strategy.
The active substance lorazepam passes into breast milk. Therefore, Lorazepam Orion should not be used during breastfeeding unless the expected benefits of treatment clearly outweigh the potential risks to the infant. Exposed infants should be monitored for excessive sedation, poor feeding, and respiratory depression.
Children and Adolescents
Lorazepam Orion should not be used by children and adolescents under 18 years of age. The safety and efficacy of lorazepam in this population have not been established, and the developing brain may be particularly vulnerable to the effects of benzodiazepines.
Driving and Operating Machinery
Lorazepam Orion has a moderate to significant impact on the ability to drive and perform tasks requiring alertness. The medication affects reaction time, causes drowsiness, sedation, and muscle relaxation, and may cause side effects such as dizziness and visual disturbances. You should not drive or operate machinery while taking lorazepam. These effects may persist into the day after taking a dose, particularly in elderly patients or those taking higher doses.
Food, Drink, and Alcohol
Tablets should be taken with a small amount of liquid and can be taken with or without food. Alcohol must not be consumed during treatment with Lorazepam Orion. Alcohol can alter and enhance the effects of lorazepam in unpredictable and potentially dangerous ways, significantly increasing the risk of excessive sedation, respiratory depression, and loss of consciousness.
Each Lorazepam Orion tablet contains 63.75 mg of lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
How Does Lorazepam Orion Interact with Other Drugs?
Drug interactions with lorazepam are clinically significant because many commonly used medications also affect the central nervous system. When two or more CNS depressants are combined, their effects can be additive or even synergistic, leading to excessive sedation, respiratory depression, cardiovascular depression, and in severe cases, coma or death. Always inform your doctor about all medications you are taking, including prescription drugs, over-the-counter medicines, and herbal supplements.
Concurrent use of Lorazepam Orion with opioid medications (strong painkillers, opioid dependence treatments, and certain cough medicines) increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can be life-threatening. This combination should only be considered when no alternative treatment options are available. If your doctor prescribes lorazepam alongside an opioid, the dose and duration must be limited. Inform friends and family members about the signs to watch for. Contact your doctor immediately if you experience any of these symptoms.
Major Interactions
| Drug Class | Examples | Effect | Risk Level |
|---|---|---|---|
| Opioid analgesics | Morphine, oxycodone, fentanyl, codeine, tramadol | Severe respiratory depression, coma, death | Critical |
| Antipsychotics | Haloperidol, olanzapine, quetiapine, risperidone | Enhanced sedation, hypotension, respiratory depression | High |
| Sedative antihistamines | Promethazine, hydroxyzine, diphenhydramine | Increased sedation and drowsiness | High |
| Antidepressants | SSRIs, SNRIs, tricyclics, MAOIs | Enhanced CNS depression, increased sedation | Moderate–High |
| Antiepileptics | Phenobarbital, phenytoin, valproate, carbamazepine | Increased or decreased lorazepam effect, additive sedation | Moderate |
| General anesthetics | Propofol, sevoflurane, ketamine | Prolonged and deepened sedation | High |
Other Notable Interactions
| Drug / Substance | Effect on Lorazepam | Clinical Significance |
|---|---|---|
| Probenecid (gout treatment) | Inhibits glucuronidation, increasing lorazepam levels | Dose reduction may be needed |
| Rifampicin (antibiotic) | Induces metabolism, may reduce lorazepam effectiveness | Monitor for reduced efficacy |
| Theophylline / Aminophylline | May reduce anxiolytic effect of lorazepam | Monitor for reduced efficacy |
| Caffeine | May reduce anxiolytic effect | Limit caffeine intake |
| Baclofen / Tizanidine | Enhanced muscle relaxation and sedation | Use combination cautiously |
| Disulfiram | May inhibit lorazepam elimination | Monitor for increased effects |
This list is not exhaustive. Always tell your doctor or pharmacist about all medications you use, have recently used, or plan to use. Even seemingly harmless over-the-counter preparations (such as sleep aids or cold medicines containing antihistamines) can interact with lorazepam and increase the risk of excessive sedation.
What Is the Correct Dosage of Lorazepam Orion?
Always use Lorazepam Orion exactly as your doctor has prescribed. The dosage and treatment duration are individualized based on the severity of symptoms, the patient's response, age, weight, overall health status, and any concurrent medications. If you are unsure about your dose, consult your doctor or pharmacist. The tablet has a score line and can be divided into two equal halves.
Adults
Anxiety Treatment
The usual daily dose is 2–3 mg divided into several doses throughout the day. The daily dose can range from 1 mg to 7.5 mg depending on individual response. The highest portion of the daily dose should be taken at bedtime to aid sleep and minimize daytime sedation.
Anxiety-Related Insomnia
For sleep disturbances caused by anxiety or transient situational stress, the usual dose is 1–2 mg taken once daily at bedtime.
Elderly and Frail Patients
Reduced Starting Dose
The recommended daily dose is 1 mg daily, divided into two doses of 0.5 mg. Elderly patients are more sensitive to the effects of benzodiazepines and are at greater risk of falls, confusion, and paradoxical reactions. The dose should be carefully titrated according to the patient's needs and tolerance, and the lowest effective dose should always be used.
Children and Adolescents
The safety and efficacy of lorazepam have not been established in children and adolescents. Lorazepam Orion should not be used in patients under 18 years of age.
Missed Dose
If you forget to take a dose of Lorazepam Orion, do not take a double dose to make up for it. Skip the missed dose and take your next dose at the regular scheduled time. Taking a double dose increases the risk of excessive sedation and other adverse effects.
Overdose
If you or someone else has taken too much Lorazepam Orion, contact your local emergency services or poison control center immediately. An overdose of lorazepam can be life-threatening, particularly when combined with other CNS depressants such as opioids or alcohol.
Symptoms of lorazepam overdose may include:
- Excessive drowsiness and deep sedation
- Mental confusion and disorientation
- Slurred speech and communication difficulties
- Unsteady movements and loss of coordination (ataxia)
- Low blood pressure (hypotension)
- Decreased muscle strength
- Respiratory depression (slow, shallow breathing)
- Fainting with weak pulse, pallor, and cyanosis (bluish discoloration of lips and nails)
- In rare cases, loss of consciousness (coma)
- In very rare cases, fatal outcome (especially with polydrug overdose)
Treatment for benzodiazepine overdose is primarily supportive, including monitoring of vital signs and maintaining an adequate airway. The specific benzodiazepine antagonist flumazenil may be used in a hospital setting, but its use requires careful medical judgment as it can precipitate seizures in dependent individuals.
What Are the Side Effects of Lorazepam Orion?
Like all medicines, Lorazepam Orion can cause side effects, although not everybody gets them. Most side effects are dose-dependent, meaning they are more likely to occur and more severe at higher doses. Many of the common side effects, particularly sedation and drowsiness, tend to diminish over the first few days of treatment as the body adjusts to the medication.
Stop taking Lorazepam Orion and contact your doctor or emergency services immediately if you experience symptoms of a severe allergic reaction (anaphylaxis) or angioedema: hives, itching, swelling of the face, lips, mouth, or throat causing difficulty swallowing or breathing. These are very rare (affecting up to 1 in 10,000 people) but require urgent medical treatment.
Very Common
Affects more than 1 in 10 people
- Drowsiness
- Fatigue
- Sedation
Common
Affects up to 1 in 10 people
- Difficulty coordinating movements (ataxia)
- Confusion
- Low mood or worsening of latent depression
- Dizziness
- Muscle weakness
- Exhaustion
Uncommon
Affects up to 1 in 100 people
- Headache and lethargy
- Emotional blunting
- Visual changes (double vision, blurred vision)
- Nausea, gastrointestinal disturbances, appetite changes
- Skin reactions
- Changes in libido, erectile dysfunction, decreased orgasm
Rare
Affects up to 1 in 1,000 people
- Blood count changes (decreased red cells, white cells, platelets)
- Transient amnesia and memory disturbances
- Elevated bilirubin, jaundice, increased liver enzymes (transaminases, alkaline phosphatase)
Very Rare
Affects up to 1 in 10,000 people
- Hypersensitivity reactions (anaphylaxis, angioedema)
- SIADH (syndrome of inappropriate ADH secretion), low sodium, hypothermia
- Tremor, vertigo, slurred speech, seizures
- Disinhibition, euphoria, paradoxical reactions (anxiety, agitation, hostility, aggression, rage, insomnia, hallucinations)
- Suicidal thoughts or attempts
- Impaired concentration, balance disturbances
- Hypotension (low blood pressure)
- Breathing difficulties, apnea, worsening of sleep apnea or obstructive lung disease
- Constipation
- Allergic skin reactions, hair loss
Drug misuse, drug dependence, and withdrawal syndrome have been reported with unknown frequency. These are recognized class effects of all benzodiazepines.
Paradoxical Reactions
In rare cases, benzodiazepines including lorazepam can cause paradoxical reactions — the opposite of the intended effect. Instead of calming anxiety, the patient may experience increased anxiety, agitation, restlessness, hostility, aggression, rage, sleep disturbances, sexual excitement, or hallucinations. These reactions are more common in elderly patients and children. If you experience any paradoxical reaction, contact your doctor immediately, as the medication will likely need to be discontinued.
Tolerance
After several weeks of regular use, you may notice that the effect of Lorazepam Orion becomes less pronounced. This is known as tolerance — a recognized pharmacological phenomenon with benzodiazepines. If this occurs, speak with your doctor. Do not increase the dose on your own, as this accelerates the development of dependence.
What Happens When You Stop Taking Lorazepam Orion?
Discontinuation of Lorazepam Orion must only be done under medical supervision. Your doctor will create a gradual dose reduction (tapering) schedule, especially if you have been taking the medication at higher doses or for an extended period. Abrupt discontinuation after prolonged use can lead to a withdrawal syndrome with symptoms that may be severe and, in rare cases, life-threatening.
Withdrawal symptoms from lorazepam may include:
- Headache and muscle pain
- Anxiety, tension, and restlessness
- Depression and irritability
- Insomnia and sleep disturbances
- Sweating and dizziness
- Confusion and disorientation
- Sensory hypersensitivity (light, sound, touch)
- In severe cases: seizures, psychosis, and delirium
In addition to withdrawal symptoms, you may experience rebound anxiety, where the original anxiety symptoms return with even greater intensity than before treatment began. This is a temporary phenomenon and typically resolves within a few days to weeks. The gradual tapering approach helps to minimize both withdrawal symptoms and rebound effects.
A typical tapering schedule involves reducing the dose by approximately 10–25% every 1–2 weeks, with the rate of reduction slowed further as the dose becomes smaller. Your doctor will individualize the tapering plan based on your specific situation, the dose you have been taking, and how long you have been on treatment.
How Should You Store Lorazepam Orion?
Proper storage of Lorazepam Orion is important to maintain the medication's effectiveness and to prevent accidental access by children or other unauthorized persons:
- Temperature: Store at or below 25°C (77°F). Do not refrigerate or freeze.
- Safety: Keep out of sight and reach of children. Because lorazepam is a controlled substance with misuse potential, store it in a secure location.
- Expiration: Do not use after the expiration date printed on the blister strip and outer carton. The expiration date refers to the last day of that month.
- Disposal: Do not dispose of medications via wastewater or household waste. Return unused or expired tablets to a pharmacy for environmentally safe disposal.
What Does Lorazepam Orion Contain?
Active Ingredient
Each tablet contains 1 mg lorazepam.
Inactive Ingredients (Excipients)
- Lactose monohydrate (63.75 mg per tablet) — a filler/binder
- Microcrystalline cellulose — a structural component
- Polacrilin potassium — a disintegrant to help the tablet dissolve
- Magnesium stearate — a lubricant used in tablet manufacturing
Appearance and Packaging
Lorazepam Orion tablets are white to off-white, round, flat tablets with beveled edges, marked with "1" on one side and a deep score line on the other side. The score line allows the tablet to be divided into two equal halves.
The tablets are available in aluminum foil strips (PE film coated) or aluminum/aluminum blister packs, in pack sizes of 20, 25, 30, 50, and 100 tablets. Not all pack sizes may be available in all markets.
Orion Corporation, Orionintie 1, FI-02200 Espoo, Finland.
Frequently Asked Questions About Lorazepam Orion
References and Sources
This article is based on the following peer-reviewed sources and international clinical guidelines:
- European Medicines Agency (EMA). Summary of Product Characteristics — Lorazepam. EMA Product Database. 2024. Available at: ema.europa.eu
- British National Formulary (BNF). Lorazepam — Prescribing Information. NICE BNF. 2025. Available at: bnf.nice.org.uk/drugs/lorazepam
- National Institute for Health and Care Excellence (NICE). Generalised Anxiety Disorder and Panic Disorder in Adults: Management (CG113). 2020. Available at: nice.org.uk/guidance/cg113
- World Health Organization (WHO). WHO Model List of Essential Medicines — 23rd List. Geneva: WHO; 2023.
- Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(5):403–439. doi:10.1177/0269881114525674
- Soyka M. Treatment of benzodiazepine dependence. N Engl J Med. 2017;376(12):1147–1157. doi:10.1056/NEJMra1611832
- Ashton CH. Benzodiazepines: How They Work and How to Withdraw (The Ashton Manual). Newcastle University. 2002. Available at: benzo.org.uk/manual
- U.S. Food and Drug Administration (FDA). FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines. 2016.
Medical Editorial Team
All medical content on iMedic is written and reviewed by qualified healthcare professionals following international evidence-based guidelines. Our editorial process ensures accuracy, objectivity, and adherence to the GRADE evidence framework. We have no commercial funding or pharmaceutical industry affiliations.
Medical Writers
Licensed physicians with specialization in clinical pharmacology and psychiatry, experienced in translating complex pharmaceutical data into accessible patient information.
Medical Reviewers
Board-certified specialists who independently verify all medical claims against current peer-reviewed literature and international treatment guidelines (WHO, EMA, NICE, BNF).
Conflict of Interest Statement: The iMedic editorial team operates independently with no pharmaceutical industry funding, sponsorship, or advertising relationships. All content is produced solely based on the best available scientific evidence.